What Dose Should I Start With for Ketamine Troches?

There Is No Universal Starting Dose

The most accurate answer to "what dose should I start with?" is: the dose your prescriber specifies after evaluating your individual health status, weight, medical history, and the condition being treated. Ketamine troche dosing is not one-size-fits-all.

That said, there are well-established starting dose ranges based on clinical experience that most responsible prescribers use as a starting point. For a deeper dive into the dose adjustment process, see our titration guide.

Typical Starting Dose Ranges by Indication

Mental Health (Depression, Anxiety, PTSD)

Common starting dose: 100 to 150 mg ketamine HCl per troche

• This is the most common starting range for adults of average weight seeking ketamine therapy for psychiatric indications
• At this dose with ~25% bioavailability, the effective systemic dose is approximately 25 to 37 mg — sufficient to begin assessing response and tolerability

Conservative starting dose (for anxious patients, first-time users, or smaller body weight):

50 to 100 mg

• More appropriate for patients with significant anxiety disorders who may have heightened sensitivity to dissociative onset
• Also appropriate for patients who are particularly small in body size or who have other risk factors for higher sensitivity

Upper starting dose (for larger patients or those with benzodiazepine tolerance):

150 to 200 mg

• Some providers start here when patients have known factors that may blunt response, such as regular benzodiazepine use or higher body weight

Chronic Pain (CRPS, Neuropathic Pain, Fibromyalgia)

Sub-dissociative analgesic starting dose: 50 to 100 mg

• Pain protocols often use lower doses targeting analgesic effects without pronounced psychoactive experience
• Allows more frequent dosing if needed without significant session commitment

Full therapeutic starting dose for pain with comorbid depression: 100 to 150 mg

• When pain management is being combined with antidepressant goals, starting doses align more with psychiatric protocols

How Body Weight Affects Dosing

Body weight is one factor in ketamine dosing — IV and IM protocols typically use weight-based dosing (mg/kg). For sublingual troches, most providers use absolute mg doses rather than weight-based dosing, but body weight influences the effective plasma concentration:

• A 200 mg troche in a 60 kg patient delivers a higher mg/kg exposure than in a 90 kg patient
• Providers often use slightly higher doses for patients with significantly higher body weight, and slightly lower doses for smaller patients

A rough reference: the standard IV depression dose of 0.5 mg/kg over 40 minutes translates to approximately 35 mg for a 70 kg patient systemically. For a troche with 25% bioavailability to deliver 35 mg systemically, the labeled troche dose would need to be 140 mg. This is why most starting doses cluster around 100 to 200 mg — they are calibrated to deliver IV-comparable systemic doses.

Why Starting Low Matters

Starting with the lowest reasonable effective dose serves several purposes:

Safety: A lower starting dose allows assessment of cardiovascular response (blood pressure and heart rate elevation) before committing to higher-dose protocols.

Anxiolytic effect: For patients anxious about the ketamine experience, a lower first dose produces a gentler, less disorienting introduction to the dissociative state.

Calibration: Your prescriber needs to see how you respond to establish whether you're a "sensitive responder" (pronounced effects at low doses) or a "higher-dose patient" (requires more drug for therapeutic effect).

Avoiding adverse events: An overwhelming first session can create lasting anxiety about treatment, making subsequent sessions less productive.

The Titration Process After the Starting Dose

Starting dose is just the beginning. After your first session, your provider evaluates:

• Did you feel any effects at all? (If no, dose may be too low)
• Were the effects appropriately therapeutic — present but not overwhelming?
• Were there any adverse effects (elevated BP, significant anxiety, nausea)?
• Did you notice any mood or symptom improvement in the days after?

Based on this, they may:

• Hold the same dose for the next 1 to 2 sessions to gather more data
• Increase by 25 to 50 mg if the session felt too mild or showed no therapeutic effect
• Decrease by 25 to 50 mg if the session was overwhelming or produced significant adverse effects

This iterative process continues until you find the therapeutic threshold — the lowest dose that reliably produces meaningful benefit.

What If My Starting Dose Doesn't Work?

If your first session produced no noticeable effects at 100 to 150 mg:

1. First, confirm technique: Was the troche properly placed? Did you avoid swallowing saliva during dissolution? Was it administered on an empty stomach?
2. If technique was correct, report the outcome to your prescriber. They will likely increase the dose for the next session.
3. Continue with the titration process — some patients need 200 to 300 mg to reach their therapeutic threshold.

Do not take extra troches from your current supply without discussing with your provider first. Self-adjusting outside the titration process bypasses the safety monitoring that makes titration safe.

Common Dose Ranges at Maintenance

For reference, here is where patients typically land after titration:

These ranges are approximations — individual variation is significant.

Why You Should Not Self-Determine Your Starting Dose

Some patients arrive at ketamine prescribers having researched dosing and having a specific number in mind. While being informed is valuable, your provider needs to determine your starting dose based on:

• Your exact weight and body composition
• Your cardiovascular history and current blood pressure
• Your concurrent medications (particularly benzodiazepines, which blunt effects)
• Your history of sensitivity to psychoactive substances
• The specific indication being treated
• Your history of anxiety reactions or difficult psychological experiences

A dose appropriate for someone else may not be appropriate for you. Trust the titration process — it exists precisely to find your optimal dose safely.

Key Takeaways

• Standard starting doses: 100 to 150 mg for psychiatric indications; 50 to 100 mg for pain management.
• Starting low and titrating upward based on response is the safest, most effective approach.
• Body weight influences optimal dosing — providers adjust accordingly.
• If the starting dose produces no effect, report it to your provider and follow the titration process.
• Never self-adjust doses between sessions or take extra troches without provider guidance.

References

• StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
• PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
• MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
• Mayo Clinic: Chronic Pain — Mayo Clinic overview of chronic pain conditions, causes, and multimodal treatment strategies
• NINDS: Chronic Pain — National Institute of Neurological Disorders and Stroke information on chronic pain mechanisms and management